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Abstract The binding of a £uorescent agonist to the acetycho-
line receptor from Torpedo electric organ has been studied by
time-resolved spectroscopy in three di¡erent environments: in
native membrane fragments, in the detergent CHAPS, and after
complexation by amphipathic polymers (‘amphipols’). Binding
kinetics was similar in the membrane and in amphipols, demon-
strating that the receptor can display unaltered allosteric tran-
sitions outside its natural lipid environment. In contrast, alloste-
ric equilibria were strongly shifted towards the desensitized state
in CHAPS. Therefore, the e¡ect of CHAPS likely results from
molecular interactions rather than from the loss of bulk physical
properties of the membrane environment. , 2002 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Transmembrane proteins are adapted to an environment
comprised of two distinct aqueous media and the highly com-
plex membrane phase [1]. Handling them in aqueous solution
requires their complexation by amphipathic molecules that
screen their hydrophobic transmembrane surface from contact
with water. Traditionally, this role is ful¢lled by detergents.
Detergents are small surfactants that cooperatively assemble
at the transmembrane surface of the protein at concentrations
close to their critical micellar concentration (CMC) [2]. When
the concentration of free detergent is lowered below the CMC,
most molecules desorb and the protein becomes insoluble.
Membrane proteins therefore have to be handled in the pres-
ence of excess detergent micelles. Detergents are, by de¢nition,
endowed with dissociating properties, which frequently prove
harmful: perturbation of functional properties if not down-
right inactivation by detergents is a recurrent concern in mem-
brane protein biochemistry.
‘Amphipols’ (AP) are amphipathic polymers designed for
making membrane proteins hydrophilic [3]. When added to
a membrane protein in detergent solution, they form with
the detergent a mixed layer at the surface of the protein [4].
Upon detergent removal, they stick to the protein [4], keeping
it water-soluble [3^7]. Membrane proteins are not denatured
by AP [3,5,6,8] and, usually, are more stable after complex-
ation by AP than they are in detergent solutions [3,5]. Little is
known, however, about the functionality of AP-complexed
proteins. In the most detailed study to date, the function of
the sarcoplasmic reticulum calcium pump was found to be
reversibly inhibited by AP, raising the possibility that AP
might interfere with protein conformational transitions [5].
The nicotinic acetylcholine receptor (nAChR) is the para-
digm of a large family of chemically gated ion channels that
play an essential role in cell communication [9]. The neuro-
muscular form is comprised of ¢ve homologous transmem-
brane subunits (K2LQN) arranged around a central ion channel
[9^11]. Agonists and competitive antagonists bind to sites lo-
cated at interfaces between the extracellular domains of the
K/N and K/Q subunits [12,13]. In the absence of ligands, the
membrane-bound receptor exists mainly (V85%) in a ‘basal’
state (B) that has a low a⁄nity for ACh and is amenable to
activation, the remnant being in a ‘desensitized’, high-a⁄nity
state (D). In both states, the ion channel is closed. Addition of
nACh shifts the equilibrium ¢rst towards an active state (A),
where the channel is open, and then towards the higher-a⁄n-
ity intermediate (I) and desensitized (D) states, both of them
with a closed channel [11]. Allosteric ligands such as non-
competitive antagonists regulate the equilibrium between
basal and desensitized states [11]. Conformational transitions
can be conveniently monitored in vitro by following the ki-
netics of binding of a £uorescent analog of ACh, dansyl-C6-
choline (DnsCho) [14,15].
It has long been recognized that the composition of the
lipid environment of the AChR in£uences its activity (see
e.g. [16], and references therein), and that its conformational
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equilibria can be perturbed by addition to the membrane of
foreign molecules such as local anesthetics, detergents or fatty
acids [17,18], as well as by solubilization with detergents
[19,20]. It has remained di⁄cult to sort out, however, to which
extent these e¡ects result from an alteration of the physical
properties of the environment (see e.g. [21,22]) or from direct
molecular interactions (see e.g. [16,23]). In the present work,
we have re-examined this question by taking advantage of the
ability of amphipols to keep membrane proteins soluble in the
absence of detergent micelles.
2. Materials and methods
2.1. Materials
Except where otherwise indicated, sources of materials were as in-
dicated in [15]. Torpedo marmorata was obtained live from the Labo-
ratoires de Biologie Marine in Arcachon or Rosco¡, France. CHAPS
and proadifen were from Sigma, K-bungarotoxin (K-Bgt) from Mo-
lecular Probes and 125I-K-Bgt from Amersham. Thin-layer chromatog-
raphy (TLC) pre-coated aluminum sheets (Silicagel 60 Kieselguhr
F254, 0.2 mm thick) were from Merck. Amphipol A8-35 was synthe-
sized as described in [3] and [14C]A8-35 (speci¢c activity, 9U108 cpm
g31) as described in [4]. ‘Phosphate bu¡er’ and ‘Tris bu¡er’ contained
5 mM Na2PO4 (resp. Tris/HCl), 1 mM EDTA, 100 mM NaCl, pH
7.2; ‘CHAPS bu¡er’ is phosphate bu¡er supplemented with 6.5 mM
CHAPS.
2.2. Preparation of nAChR
Receptor-rich membranes from T. marmorata electric organ [24]
were treated at pH 11 in order to remove extrinsic proteins [25].
Alkaline-treated membranes were solubilized by the addition of
CHAPS bu¡er (6.5 mM ¢nal concentration) [15] to reach a ¢nal
protein concentration of 1 g l31. The samples were centrifuged 45
min at 18 000Ug in the 45Ti rotor of a L8 centrifuge (Beckman)
and the supernatant concentrated to 15^20 g l31 using Centricon
100 devices (Amicon; cut-o¡ 100 kDa). This step ought to eliminate
V95% of free micelles.
2.3. Trapping with amphipols
In most experiments, CHAPS-solubilized nAChR (diluted to 1.4^
5.8 g l31 with CHAPS bu¡er) was supplemented with AP to reach
nAChR/A8-35/CHAPS weight ratios of 1:3:0.7^3. After incubation
for 20 min at 4‡C, samples were diluted 10U with detergent-free
phosphate bu¡er. The CHAPS concentration thereby fellV7U below
its CMC (V4 mM; see [26]). Samples were centrifuged 30 min at
18 000Ug as described above. The yield of protein in the supernatant
was 87U10%.
2.4. Protein and lipid analysis
Protein concentrations were determined either as described in [27],
with bovine serum albumin as a standard, or, for puri¢ed receptor,
from the optical density at 280 nm, using O280 = 1.2 g31 l cm31 [15].
DnsCho binding site concentrations were determined by steady-state
£uorescence measurements [15].
Lipids were extracted as described in [28,29]. Extracts in chloroform
were applied to TLC plates, which were developed with 65/25/4 (v/v/v)
chloroform/methanol/water. Phospholipids were identi¢ed from their
Rf , using standards and stains described in [30], and quanti¢ed by
phosphorus analysis [31]. Cholesterol was identi¢ed from its Rf : the
iodine-stained spot at the migration front was scratched from the
plates, eluted in chloroform/methanol 1/1 (v/v), applied onto a second
plate, and eluted along with a cholesterol standard using petroleum
ether (bp 40^65)/ethyl ether/glacial acetic acid 70/30/1 (v/v/v) as a
solvent.
2.5. Rate zonal centrifugation
250 Wl samples were centrifuged for 17 h at 160 000Ug at 4‡C on
11 ml 5^20% (w/w) continuous sucrose gradients, containing or not
6.5 mM CHAPS, in the SW41 rotor of an L8 ultracentrifuge (Beck-
man), as described in [32]. The distribution of nAChR subunits was
determined by analyzing aliquots of gradient fractions by SDS^PAGE
on 10% polyacrylamide gels, which were silver-stained as described in
[33].
Quantitative analysis of nAChR distribution was performed using
samples preincubated for 5 h at 4‡C in CHAPS bu¡er with a 12U
molar excess of bungarotoxin (125I-K-Bgt isotopically diluted with
unlabeled K-Bgt). Some of the samples were then supplemented with
A8-35 at a 1:80:40 AChR/A8-35/CHAPS weight ratio, incubated for
15 min at 4‡C and diluted below the CMC of CHAPS. Sucrose gra-
dient fractionation was carried out as described above. Fractions were
counted in an LKB 1275 MiniGamma system. Because of the low
speci¢c activity of [14C]A8-35, double-labeling was impractical, and
the mass ratio of AP to protein in nAChR/A8-35 particles was esti-
mated by combining data from parallel experiments: CHAPS-solubi-
lized nAChR was reacted with unlabeled K-Bgt and trapped with
[14C]A8-35, and the resulting complexes fractionated as described
above. 50 Wl aliquots of each gradient fraction were supplemented
with 5 ml Aqualuma Plus counting medium (Lumac LSC) and
counted in a Beckman liquid scintillation system LS 1801. Control
experiments included determining the distribution of free 125I-K-Bgt
and free [14C]A8-35 in identical gradients run in parallel. Sedimenta-
tion coe⁄cients in water at 20‡C (s20;w) were determined from these
data using abacuses calculated by interpolation from published tables
[34], assuming the partial speci¢c volume of the particles to be 0.75
cm3 g31. This value, calculated for pure nAChR [10], is underesti-
mated given the presence of bound lipids, CHAPS and/or AP. This
entails a slight underestimate of s20;w.
For lipid analysis, unbound lipids trapped in protein-free surfactant
micelles were separated from the nAChR dimer by sucrose gradient
sedimentation. The heavy form of the receptor was collected and
transferred to Tris bu¡er by ¢ve rounds of 5U concentration/dilution
cycles using Centricon 10 devices.
2.6. Analysis of nAChR allosteric transitions
The kinetics of binding of DnsCho (2 WM) to the nAChR (0.4 g l31
total protein) was followed at 20‡C using a stopped-£ow instrument
equipped with £uorescence detection (Biologic), as described in
[14,15,35]. Samples were excited at 296U4 nm and light collected
above 420 nm using a high-pass ¢lter [15]. A 0.5 ms sampling period
was used for the ¢rst second of detection and a 200 ms one for the rest
of the kinetics. The time scale was corrected for the dead time of the
instrument (3.1 ms). Binding kinetics was followed in the absence or
presence of two antagonists, a competitive one, K-Bgt (1 WM), and a
non-competitive, desensitizing one, proadifen (30 WM), after 1 h pre-
incubation at room temperature. They were analyzed as the sum of
three exponentials [14,35]:
F296 ¼ ðatþ bÞ þ
X3
i¼1
mie3kit
where F296 is the £uorescence intensity detected upon excitation at 296
nm, ki and mi are the time constant and the amplitude of exponential
i, respectively, and a and b de¢ne the straight line to which the ki-
netics tends. The quality of the ¢t was determined from the non-
normalized deviation between experiment and theory at each time
point:
DevðiÞ ¼ F 296calcðiÞ3F296expðiÞ
Attempts to ¢t the data with four exponentials led either to no con-
vergence or to degenerate solutions without any improvement of the
average weighted residual.
3. Results
3.1. nAChR dispersity
Three kinds of preparations were analyzed by sedimenta-
tion on sucrose gradients, namely 125I-Bgt-labeled nAChR in
6.5 mM CHAPS (a) and the same preparation diluted below
the CMC of CHAPS following (b) or not (c) addition of AP
A8-35. In case a, gradients contained 6.5 mM CHAPS; in
cases b and c, they contained neither detergent nor AP. Gra-
dient fractions were analyzed by SDS^PAGE and Q counting.
When CHAPS was diluted below its CMC in the absence of
AP (case c), most of the nAChR aggregated and formed a
pellet at the bottom of the tube (data not shown). The absence
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of radioactivity in the pellet indicated that the aggregated
receptor had denatured, releasing the radioactive toxin (data
not shown). Under the other two conditions, no or very little
pellet was present, the nAChR migrating as a light and a
heavy form (Fig. 1). Each form comprised the four receptor
subunits, indicating that both CHAPS and AP had preserved
the quaternary structure of the K2LQN oligomer (data not
shown).
Both receptor forms were observed to migrate slightly more
slowly once trapped by A8-35 than they did in the presence of
CHAPS: s20;w values were 9.7 U 0.3 s in AP vs. 10.3U 0.3 s in
CHAPS for the light form, and 14.7U 0.3 s in AP vs.
15.4U 0.3 s in CHAPS for the heavy one. These values are
close to those reported for the sedimentation coe⁄cients of
the monomeric and dimeric forms of the nAChR (8.7^9.5 s
and 12.5^14.4 s, respectively, depending on the nature of the
detergent; see [10,26,36], and references therein).
3.2. Speci¢c activity
The speci¢c activity of the samples was estimated from
steady-state £uorescence measurements using DnsCho
[15,37,38]. nAChR in crude membranes had a speci¢c activity
of 1.95U 0.25 nmol of agonist binding sites per mg of total
protein (i.e. V30% nAChR in mass). This rose to 6.0U 1.4
(V90% in mass) after alkaline treatment and solubilization by
CHAPS, in keeping with the prominence of the bands corre-
sponding to the nAChR subunits as seen by SDS^PAGE. A8-
35-trapped nAChR had a speci¢c activity of 5.3 U 0.8 (V80%
in mass), which is not signi¢cantly di¡erent from that in
CHAPS. Most if not all of the nAChR, therefore, remained
able to bind agonists following trapping with AP.
3.3. Amphipol/nAChR mass ratio in the complexes
AP binding to the nAChR was examined by sucrose gra-
dient fractionation of preparations trapped with [14C]A8-35
[4]. The distribution comprised two peaks, with sedimentation
coe⁄cients corresponding to those of nAChR light and heavy
forms, superimposed on a background of free AP (data not
shown). The amount of AP bound to the heavy form was
0.28U 0.03 g/g. That bound to the light form was more di⁄-
cult to establish because of the higher background of free AP,
but did not appear signi¢cantly di¡erent. This ratio is com-
parable to that found (using a slightly di¡erent AP) for an-
other protein of comparable transmembrane size, the cyto-
chrome b6 f dimer [4,8].
3.4. Lipid content
TLC revealed the presence in preparations of CHAPS-solu-
bilized and AP-trapped nAChR of phosphatidylserine, phos-
phatidylethanolamine, phosphatidylcholine and cholesterol.
This composition is similar to that of T. marmorata recep-
tor-rich membranes [30]. Phosphorus analysis yielded compa-
rable results for complexes with either CHAPS or A8-35,
namely 71U 5 and 88U 6 phospholipids per nAChR dimer,
respectively, suggesting that all of the lipids associated with
the protein in CHAPS solution remain bound to it upon
transfer to AP. This is comparable to theV90 phospholipids
per dimer that have been found to be required for keeping
solubilized nAChR from inactivating [39]. The presence of
V130 tightly associated phospholipids per dimer of
CHAPS-solubilized nAChR has been reported previously [26].
3.5. Allosteric transitions
Binding of DnsCho to the ACh binding sites was studied
using stopped-£ow measurements. The kinetics can be ¢tted
by three exponentials [14,15,35] : a rapid phase (ms range)
re£ects binding of the ligand to receptor molecules in the
high-a⁄nity D state, whereas conformational transitions
from the low-a⁄nity B state to the I and D states give rise
to the slower phases (min range). Thus, the relative amplitude
of the rapid phase (Table 1, parameter m3) re£ects the fraction
of nAChR that pre-exists in the D state prior to the addition
of DnsCho.
In native membranes, 11 U 2% of the nAChR population
pre-exists in the D state (Fig. 2 and Table 1). Upon preincu-
bation with the non-competitive antagonist proadifen, the de-
sensitized population rises to 85U 10%. These values are in
good agreement with the literature [40,41]. Similar results
were obtained whether the membranes had been treated at
pH 11 or not (data not shown). In CHAPS solution,
Fig. 1. Migration of CHAPS-solubilized and AP-trapped nAChR
during centrifugation on sucrose gradients. CHAPS-solubilized
nAChR was labeled with 125I-K-Bgt. An aliquot (R) was fractionat-
ed by ultracentrifugation on a 5^20% sucrose gradient in CHAPS
bu¡er (see Section 2). A second aliquot (8) was supplemented with
AP A8-35, diluted 6U (i.e. V4U below the CMC of CHAPS) with
phosphate bu¡er, and centrifuged on a gradient containing neither
CHAPS nor AP. Solid symbols and dashed lines refer to rough
data, empty symbols and solid lines to the pro¢le obtained follow-
ing subtraction of the background of free 125I-K-Bgt, estimated from
parallel experiments.
Table 1
Time constants and pre-exponential coe⁄cients describing the kinetics of binding of DnsCho to nAChR in di¡erent environments
Native membrane CHAPS A8-35
m1 (%) 43U 12 26U 6 54U 3
k1 (s31) 0.06U 0.02 0.11U 0.06 0.04U 0.01
m2 (%) 46U 11 17U 5 32U 7
k2 (s31) 0.5 U 0.3 0.6 U 0.3 0.31U 0.16
m3 (%) 11U 2 57U 9 14U 5
k3 (s31) 50U 6 58U 10 85U 19
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57U 9% of the nAChR population pre-existed in the high-
a⁄nity state (Fig. 2 and Table 1), rising to 80U 10% after
preincubation with proadifen. This shift of the resting confor-
mational equilibrium towards the desensitized state is compa-
rable to that previously reported for nAChR solubilized in
lipid/cholate [20] or lipid/Triton X-100 [35] mixtures. Follow-
ing addition of A8-35 and dilution under the CMC of
CHAPS, 14U 5% of the population pre-existed in the D state
(Fig. 2 and Table 1), rising to 70U 9% after preincubation
with proadifen. Whatever the environment (native mem-
branes, CHAPS micelles or AP), preincubation of the nAChR
with K-Bgt abolished the £uorescence transient, indicating
that it does report on speci¢c binding to the ACh binding
sites. The rate of interconversion between conformational
states, which is re£ected in rate constants k1 and k2, did not
vary signi¢cantly among the three kinds of samples (Table 1).
Thus, while the equilibrium between allosteric states is
modi¢ed when the nAChR is solubilized in CHAPS, it shifts
back to ¢gures typical of the membrane-bound state following
addition of A8-35 and dilution of the detergent below its
CMC.
4. Discussion
Allosteric properties of two soluble forms of nAChR were
examined and compared to those exhibited by the protein in
its native membrane environment. CHAPS-solubilized
nAChR, with native lipids present but no exogenous lipids
added, undergoes allosteric transitions between the basal (B)
and desensitized (D) conformational states upon addition of
DnsCho. However, as previously observed in other lipid/de-
tergent mixed environments [19,20,35,40], the conformational
equilibrium in the absence of agonist is shifted towards the
D state. AP-trapped nAChR was prepared by adding amphi-
pol A8-35 to CHAPS-solubilized nAChR and diluting the
preparation below the CMC of the detergent. In the absence
of AP, this resulted in the precipitation and denaturation of
the protein. In its presence, the nAChR remained both soluble
and functional. AP-stabilized nAChR retained the lipids asso-
ciated with the CHAPS-solubilized form and displayed a rest-
ing B/D ratio similar to that observed in the membrane envi-
ronment. This return to native-like allosteric transitions was
achieved by mere dilution, without e¡ective removal of the
detergent.
These data o¡er an opportunity to distinguish between a
physical and a molecular mechanism for the displacement of
nAChR allosteric equilibria. Upon solubilization with
CHAPS, the membrane environment of the receptor is re-
placed with a mixed belt of detergent and endogenous lipids
([26], and present work). Perturbation of the resting equilib-
Fig. 2. Kinetics of DnsCho binding to native receptor-rich membranes (A,B), CHAPS-solubilized nAChR (C,D) and nAChR trapped by A8-35
(E,F). Kinetics is represented on two time scales, from 0 to 0.25 s for the rapid phase (A,C,E), and from 0 to 100 s for the overall process
(B,D,F). Fitting parameters, averaged over 4^5 preparations, are given in Table 1. Dev(I): residual of the ¢t.
FEBS 26515 11-9-02
K.L. Martinez et al./FEBS Letters 528 (2002) 251^256254
rium a priori could result from (i) the modi¢cation of bulk
physical properties (electrostatic ¢eld, lateral pressure, viscos-
ity, local dielectric constant, accessibility to water etc.; see e.g.
[21,22]), or (ii) the displacement by CHAPS of some of the
lipids that interact with the protein in its native environment.
After addition of AP and dilution below the CMC of the
detergent, the nAChR is surrounded with a mixed layer of
AP and lipids, likely interspersed with residual CHAPS mol-
ecules. This third medium again is very di¡erent from the ¢rst
two. For instance, the coverage of the protein transmembrane
surface by AP is likely to be less dense than that by detergent
molecules [4], probably entailing a di¡erent accessibility to
water. The electrostatic ¢eld also is profoundly di¡erent.
The forces that the nAChR experiences after complexation
by A8-35 di¡er even more profoundly from those imposed
upon it by the native membrane environment. In particular,
variations of dielectric constant, electrostatic potential or lat-
eral pressure along the transmembrane surface, if present at
all, cannot be expected to mimic the strong transmembrane
gradients which surround the protein in situ. Its return to
native-like allosteric properties therefore is much more likely
to result from molecular interactions than from general phys-
ical e¡ects. This tallies with the view that the membrane-
bound receptor is more sensitive to the chemical composition
of the lipid phase than it is to its physical properties [16,23].
Competition with lipids has been proposed as the cause of
the local anesthetic-like e¡ects of detergents [35] and fatty
acids [16] on membrane-bound nAChR. Similarly, inhibition
by the steroid promegestone has been tentatively linked to the
displacement of cholesterol from the nAChR/lipid interface
[42]. In the likely event that the desensitizing e¡ect of CHAPS
involves its displacing lipids from the nAChR surface, two
kinds of mechanisms may be considered: (i) binding of lipid
molecules promotes the basal state, or (ii) binding of CHAPS
favors the desensitized state. This leads to two possible types
of explanation for the relieving e¡ect of replacing CHAPS
with AP. Both of them rest on CHAPS being displaced
from sites it binds to in detergent solution; however, in the
¢rst case, it is postulated that the critical factor is that lipids
rebind to these sites; in the second, that the detergent be
chased from them, whether it be by lipids or by AP.
In conclusion, the present work shows that a protein with
such complex conformational transitions as the nAChR re-
covers, once trapped by AP, functional properties that are
much closer to those it exhibits in its native membrane envi-
ronment than to those observed in detergent solution. Molec-
ular interactions therefore appear to have more importance
than bulk physical forces in regulating the functional proper-
ties of the nAChR. It will be of interest to further examine the
e¡ects of AP on the activity and dynamics of other proteins
whose function requires transmembrane conformational
changes, and the role of bound lipids and residual detergent
in facilitating these movements [5]. As regards the nAChR,
AP make it possible to handle it in aqueous solutions in the
absence of detergent micelles, under a functional form, while
retaining the methodological advantages of an isotropic aque-
ous medium. This should be of interest for structural, bio-
physical and pharmacological investigations.
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